THURSDAY, Feb. 6, 2025 -- A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful,...
Vous n'êtes pas connecté
THURSDAY, Feb. 6, 2025 -- Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell carcinoma (RCC) and can target key driver mutations and induce antitumor immunity, according to a study...
THURSDAY, Feb. 6, 2025 -- A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful,...
A new personalized cancer vaccine has shown encouraging results in preventing the return of kidney cancer after surgery. Researchers at Dana-Farber...
RESEARCH SUMMARY Study Title: Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma...
medlinkMerkel cell carcinoma/medlink is a rare but highly aggressive medlinkskin cancer/medlink. It is difficult to treat typically affecting
Discover how AI-powered DeepMerkel improves survival predictions for Merkel cell carcinoma, offering personalized treatment insights for better...
Samantha Humphreys is charged with leading MSD’s Irish business including key cancer drug and vaccine plants
MONDAY, Feb. 10, 2025 -- For individuals with type 1 diabetes, intraindividual body weight variability, or body weight cycling, is associated with an...
American scientists from the University of Florida achieved a breakthrough in the development of Salmonellose vaccines, one of the most dangerous food...
TUESDAY, Feb. 11, 2025 -- Some risk factors for epithelial ovarian cancer are modifiable, according to a study published online Jan. 6 in the...
A new study has found that taking a small daily dose of aspirin could help stop colon cancer from returning in some patients. The research shows that...